A Phase 3 interventional study of Lithium Carbonate and Placebo in Carotid Artery Diseases and Carotid Artery Stenosis, sponsored by Negovsky Reanimatology Research Institute. Terminated at 1 site in Russia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-25.
Sponsored by Negovsky Reanimatology Research Institute · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
There are 10.3 million cases of stroke registered in the world every year; 63% of them lead to death. According to World Health Organization, stroke is one of the most important risk factors of death and early disability.
Carotid artery surgery is a gold standard of hemodynamically significant carotid artery disease treatment. According to some trials, carotid artery surgery decreases the 2-years mortality.
The most important part of carotid artery surgery is a temporary absence of blood flow in the carotid artery. The duration of this period is a crucial characteristic of this type of surgery. The absence of blood flow leads to brain ischemia which is the risk factor of postoperative neurocognitive disorders such as emergence delirium, postoperative delirium and postoperative cognitive dysfunction.
Some surgical and non-surgical methods for brain protection were evaluated. According to recent data, there is no evidence of effective pharmacological protective methods that can decrease brain damage during carotid artery surgery.
Nevertheless, some trials demonstrated that using lithium-based medications for patients with a stroke can reduce the volume of the stroke. Therefore, the investigators want to check the hypothesis that using lithium-based medication in the preoperative period can reduce brain damage during carotid artery surgery.
The objectives of this trial:
There are 10.3 million cases of stroke registered in the world every year; 63% of them lead to death. According to World Health Organization, stroke is one of the most important risk factors of death and early disability.
Carotid artery surgery is a gold standard of hemodynamically significant carotid artery disease treatment. According to some trials, carotid artery surgery decreases the 2-years mortality.
The most important part of carotid artery surgery is a temporary absence of blood flow in the carotid artery. The duration of this period is a crucial characteristic of this type of surgery. The absence of blood flow leads to brain ischemia which is the risk factor of postoperative neurocognitive disorders such as emergence delirium, postoperative delirium and postoperative cognitive dysfunction.
Some surgical and non-surgical methods for brain protection were evaluated. According to recent data, there is no evidence of effective pharmacological protective methods that can decrease brain damage during carotid artery surgery.
Nevertheless, some trials demonstrated that using lithium-based medications for patients with a stroke can reduce the volume of the stroke. Therefore, the investigators want to check the hypothesis that using lithium-based medication in the preoperative period can reduce brain damage during carotid artery surgery.
The objectives of this trial:
To determine if Lithium carbonate is superior to placebo for the occurrence of emergence delirium, agitation, postoperative delirium and postoperative cognitive dysfunction.
To determine if Lithium carbonate is non-inferior to placebo for the occurrence of a new arrhythmia, leukocytosis, acute kidney injury, seizure disorders, diarrhea, nausea, and vomit.
369 studies on the registry are indexed under Carotid Stenosis; 88 are open to participants now.
This study's enrollment of 107 is close to the median of 102 across 192 interventional studies indexed under Carotid Stenosis.
Browse Carotid Stenosis studies →Negovsky Reanimatology Research Institute is the lead sponsor of 10 studies on the registry; 2 are open to participants now.
Compared within Carotid Stenosis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Carotid Artery Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
In preoperative period patients will take 300mg of lithium carbonate on 1-1-1 regimen during 2 days prior to surgery. On the day of surgery, they will take 300mg of lithium carbonate 2 hours before surgery. After the surgery, patients will take 300mg of lithium carbonate in the afternoon and 300mg of lithium carbonate in the evening.
Drug: Lithium Carbonate
In preoperative period patients will take placebo on 1-1-1 regimen during 2 days prior to surgery. On the day of surgery, they will take placebo 2 hours before surgery. After the surgery, patients will take placebo in the afternoon and in the evening.
Drug: Placebo
In preoperative period patients will take 300 mg of lithium carbonate on 1-1-1 regimen during 2 days prior to surgery. On the day of surgery they will take 300mg of lithium carbonate 2 hours before surgery.
In preoperative period patients will take placebo on 1-1-1 regimen during 2 days prior to surgery. On the day of surgery they will placebo 2 hours before surgery.
Frequency of emergence delirium
Number of patients with positive the confusion assessment method for the intensive care unit as soon as they reach Aldrete score of 9 points
Time frame: 30 days
Frequency of agitation
Richmond agitation-sedation scale more or equal +2 evaluated from the end of volatile anesthetic supply to the moment when a patient reaches Aldrete score of 9 points Richmond agitation-sedation scale: minimum value = -5 (Unarousable - no response to voice or physical stimulation) maximum value = +4 (Combative - overtly combative or violent; immediate danger to staff) Adequate patients have the results of Richmond agitation-sedation score equal 0 (Alert and calm; Spontaneously pays attention to caregiver)
Time frame: 30 days
Frequency of postoperative delirium
Number of patients with even one positive confusion assessment method for the intensive care unit or 3-minute confusion assessment method
Time frame: 30 days
Length of postoperative delirium
30 days - number of days in which patient had positive confusion assessment method for the intensive care unit or 3-minute confusion assessment method
Time frame: until 1 month after surgery
Frequency of overt strokes
Number of overt strokes
Time frame: 1 year
Frequency of covert strokes
Number of covert strokes
Time frame: 1 year
Length of stay in intensive care unit
Number of days in intensive care unit
Time frame: 1 month
Length of hospitalization
Number of days in hospital
Time frame: 1 month
Frequency of cardiac death
Number of of cardiac deaths
Time frame: 1 year
Frequency of non-fatal cardiac arrest
Number of non-fatal cardiac arrests
Time frame: 1 year
Frequency of major adverse cardiac event
Number of major adverse cardiac events
Time frame: 1 year
Frequency of major adverse cardiac and cognitive event
Number of major adverse cardiac and cognitive events
Time frame: 1 year
30-days mortality
Number of deaths in period of 30 days after surgery
Time frame: 30 days
1-year mortality
Number of deaths in period of 1 year after surgery
Time frame: 1 year
Frequency of new postoperative arrhythmia
Number of new postoperative arrhythmias
Time frame: 1 month
Frequency of leukocytosis
Number of patients with leukocytosis
Time frame: From 2 days before surgery to the day of surgery
Frequency of acute diarrhea
Number of patients with acute diarrhea
Time frame: From 2 days before surgery to the day of surgery
Frequency of postoperative nausea and vomit
Number of patients with postoperative nausea and vomit
Time frame: 1 month
Frequency of preoperative nausea and vomit
Number of patients with preoperative nausea and vomit
Time frame: From 2 days before surgery to the day of surgery
Frequency of acute kidney injury
Number of patients with acute kidney injury
Time frame: 1 month
Frequency of myasthenia
Number of patients with myasthenia
Time frame: From 2 days before surgery to the day of surgery
Frequency of preoperative seizure
Number of patients with seizure
Time frame: From 2 days before surgery to the day of surgery
Frequency of postoperative seizure
Number of patients with seizure
Time frame: 1 month
Serum level of S100 beta protein
Serum level of S100 beta protein
Time frame: 2 days after surgery
Serum level of neuron-specific enolase
Serum level of neuron-specific enolase
Time frame: 2 days after surgery
Serum level of Tau-protein
Serum level of Tau-protein
Time frame: 2 days after surgery
Serum level of Neurofilament light polypeptide
Serum level of Neurofilament light polypeptide
Time frame: 2 days after surgery
Serum level of Glial fibrillary acidic protein
Serum level of Glial fibrillary acidic protein
Time frame: 2 days after surgery
Ran from Nov 2021 to primary completion in May 2025, 41 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Lithium Carbonate
Negovsky Reanimatology Research Institute